Compare Abbott Laboratories (ABT) vs American Homes 4 Rent Class A (AMH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs American Homes 4 Rent Class A — how do they compare? Abbott Laboratories trades at $95.37 (market cap $166.94B), while American Homes 4 Rent Class A trades at $33.47 (market cap $12.23B). The key difference: Abbott Laboratories is far larger — about 13.7× American Homes 4 Rent Class A's market cap, and American Homes 4 Rent Class A pays the higher dividend (3.88%). Which is the better fit depends on your goals.
| ABT | AMH | |
|---|---|---|
Market Cap | $166.94B | $12.23B |
Sector | Health | Real Estate |
52-Week High | $136.62 | $36.74 |
52-Week Low | $82.57 | $27.38 |
Enterprise Value | $193.69B | $17.32B |
Dividend Yield | 2.63% | 3.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
AMH trades at $34.00, down 0.23% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $35.41. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.35 exceeding expectations of $0.1763. Revenue grew to $1.85 billion in 2025, with a net income margin of 25.27%, while the stock trades at a P/E of 27.45 and P/S of 6.69. A dividend of $0.33 per share is scheduled for payment on June 30, 2026.
AMH presents a positive outlook driven by consistent earnings performance and robust fundamentals, though elevated valuation ratios and high debt levels pose risks. Investor sentiment is supported by bullish analyst ratings and strong occupancy rates in the single-family rental market, but macroeconomic factors and interest rate sensitivity remain key considerations for potential investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About American Homes 4 Rent Class A
American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Read more on AMH →
